Matt Hewitt
Stock Analyst at Craig-Hallum
(2.69)
# 1,979
Out of 4,886 analysts
40
Total ratings
51.35%
Success rate
4.12%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $16.83 | +113.90% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $8.50 | +41.18% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $2.89 | +107.61% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $21.83 | +46.59% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $28.92 | +121.30% | 6 | Oct 31, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $2.05 | +387.80% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $20.63 | +45.42% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $2.17 | +222.58% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $124.43 | +60.73% | 3 | Aug 3, 2023 | |
| OABI OmniAb | Initiates: Buy | $10 | $1.87 | +434.76% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $8.07 | +271.75% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.96 | +41,566.67% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $16.83
Upside: +113.90%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $8.50
Upside: +41.18%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.89
Upside: +107.61%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $21.83
Upside: +46.59%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $28.92
Upside: +121.30%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $2.05
Upside: +387.80%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $20.63
Upside: +45.42%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $2.17
Upside: +222.58%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $124.43
Upside: +60.73%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.87
Upside: +434.76%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $8.07
Upside: +271.75%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.96
Upside: +41,566.67%